Long-term (10 years or more) follow-up of outcomes after antireflux surgery: a systematic review of efficacy, complications, and reoperation rates
Journal of Gastrointestinal Surgery Open · 2026-11 · 6 · 100047
DOI: 10.1016/j.jogsop.2026.100047 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Gastrointestinal Surgery Open, 2026-11. Verfasst von Maitreyi Patel und 5 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Fundoplication is the most common surgical treatment for severe gastro-oesophageal reflux disease, with a reported long-term failure rate of 10-15%. Operative failure, usually defined as recurrent reflux and/or dysphagia, can reduce quality of life, and a minority of cases require revisional surgery. We performed a systematic review of anti-reflux surgery to summarise the evidence for long-term safety and efficacy.
Methods
Following PRISMA guidelines, we searched MEDLINE, Embase and Cochrane databases for randomised controlled trials and high-quality non-randomised studies of anti-reflux surgery in adults with gastro-oesophageal reflux disease that reported follow-up of 10 years or longer. Outcomes assessed were complications, reoperation rate and long-term proton pump inhibitor use.
Results
Thirty-one reports representing 25 independent studies (5,173 patients enrolled; 3,467 followed for ≥10 years; five continents; mean age 46-67 years) met the inclusion criteria. Intraoperative complications were rare: respiratory events 1.5%, gastro-oesophageal perforation 0.9%, and conversion to open surgery 2.8%. Long-term data were reported for 3,467 patients. Functional symptoms were common but heterogeneously reported: dysphagia across 12 studies (study-level range 0-48%), gas bloating across 8 studies (0-75%) and inability to vomit or belch across 7 studies (0-92%). The descriptive pooled reoperation rate was 7.14% (18 cohorts; range 0-43%), mainly for recurrent reflux and wrap-related complications, and 12.83% remained on long-term proton pump inhibitor therapy at 10 years or beyond (15 cohorts; range 0-61%). Given clinical and reporting heterogeneity, these are descriptive summaries rather than meta-analytic estimates.
Conclusion
While intraoperative events are infrequent, long-term outcomes warrant attention. The efficacy of fundoplication declines over time, reflected in continued proton pump inhibitor use and an increased reoperation rate representing late failures. This evidence will inform the consent process.
Zitieren
APA
Patel, M., Butnari, V., Ahmed, M., El-Gazzar, M., Parmar, C., & Mukherjee, S. (2026). Long-term (10 years or more) follow-up of outcomes after antireflux surgery: a systematic review of efficacy, complications, and reoperation rates. Journal of Gastrointestinal Surgery Open, 6, 100047. https://doi.org/10.1016/j.jogsop.2026.100047
Vancouver
Patel M, Butnari V, Ahmed M, El-Gazzar M, Parmar C, Mukherjee S. Long-term (10 years or more) follow-up of outcomes after antireflux surgery: a systematic review of efficacy, complications, and reoperation rates. Journal of Gastrointestinal Surgery Open. 2026;6:100047. doi:10.1016/j.jogsop.2026.100047
BibTeX
@article{Patel2026,
author = {Patel, Maitreyi and Butnari, Valentin and Ahmed, Mehnaz and El-Gazzar, Mohamed and Parmar, Chetan and Mukherjee, Samrat},
title = {Long-term (10 years or more) follow-up of outcomes after antireflux surgery: a systematic review of efficacy, complications, and reoperation rates},
journal = {Journal of Gastrointestinal Surgery Open},
year = {2026},
volume = {6},
pages = {100047},
doi = {10.1016/j.jogsop.2026.100047}
}
EUVIMED